Clinical Trials Directory

Trials / Completed

CompletedNCT07209722

PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare

Status
Completed
Phase
Study type
Observational
Enrollment
1,377 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrEP acronym (pre-exposure prophylaxis)Tracked PrEP prescriptions over 8 months among patients who completed the survey

Timeline

Start date
2023-09-22
Primary completion
2025-08-16
Completion
2025-08-16
First posted
2025-10-07
Last updated
2026-01-26
Results posted
2026-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07209722. Inclusion in this directory is not an endorsement.